1.
Armstrong A, Lebwohl M, Stein Gold L, Jacobson A. Brodalumab Provides Rapid Onset of Therapeutic Response for Patients With Moderate-to-Severe Psoriasis. J of Skin [Internet]. 2023Mar.13 [cited 2024Jul.22];7(2):s133. Available from: https://jofskin.org/index.php/skin/article/view/1986